GHRP-6 is a chain of six amino acids. It switches on GHSR1a, the growth hormone secretagogue (a compound that prompts your body to release growth hormone) receptor. This is a GPCR (a type of docking site on the cell surface) found on somatotroph cells (growth-hormone-making cells) in the front part of the pituitary (the master hormone gland at the base of the brain) gland and on nerve cells in the hypothalamus (a control center in the brain). Step by step: GHRP-6 attaches to GHSR1a and activates Gq/11 G-proteins (internal relay switches). That turns on phospholipase C, which raises calcium inside the cell and activates protein kinase C (an enzyme). This makes somatotroph cells depolarize (their electric charge shifts) and release granules (packets) of growth hormone. This route is different from GH release triggered by GHRH (the brain's natural GH signal), and the two work together. Recent research found GHSR1a on tissues outside the pituitary, including heart muscle cells, blood vessel lining, and immune cells. That helps explain GHRP-6's heart-protecting and cell-protecting effects, which do not depend on raising GH. The half-life (how long it stays active in your body) is short (~2.5 hours), so several doses a day are needed to keep GH up. Constant stimulation can cause receptor desensitization (the receptor stops responding) and internalization (the cell pulls the receptor inside), which is the reason for cycling protocols (on-and-off schedules).